share_log

金石亚药(300434.SZ):暂未应用AI技术于药物研发

Jinshi Asia Pharmaceutical (300434.SZ): AI technology has not been applied in drug research and development

Gelonghui Finance ·  Apr 30 03:06

Gelonghui, April 30 | Jinshi Yayao (300434.SZ) said on the investor interactive platform that currently the application of AI technology in drug development mainly focuses on drug design and optimization, prediction of adverse reactions and clinical trials, and patient recruitment. The company has not yet applied AI technology to drug research and development. The company is actively promoting drug research and development through multiple channels such as independent research and development, outsourced R&D, and document acquisition. Please pay attention to the company's announcements regarding the company's drug development.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment